{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:30:17Z","timestamp":1792672217293,"version":"4.5.0"},"reference-count":122,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s10787-025-01936-2","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T08:44:12Z","timestamp":1757493852000},"page":"5689-5717","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Effect of pentoxifylline on serum levels and gene expression of inflammatory markers: a systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7474-1763","authenticated-orcid":false,"given":"Banafsheh","family":"Safizadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8171-1650","authenticated-orcid":false,"given":"Sahar","family":"Yarahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6534-2907","authenticated-orcid":false,"given":"Farzad","family":"Sadri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6823-8638","authenticated-orcid":false,"given":"Elham","family":"Bahreini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1819-853X","authenticated-orcid":false,"given":"Yaser","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taraneh","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,10]]},"reference":[{"issue":"4","key":"1936_CR1","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S1043-6618(03)00002-1","volume":"47","author":"OM Abdel-Salam","year":"2003","unstructured":"Abdel-Salam OM, Baiuomy AR, El-Shenawy SM, Arbid MS (2003) The anti-inflammatory effects of the phosphodiesterase inhibitor pentoxifylline in the rat. Pharmacol Res 47(4):331\u2013340","journal-title":"Pharmacol Res"},{"issue":"5","key":"1936_CR2","doi-asserted-by":"publisher","first-page":"627","DOI":"10.14202\/vetworld.2018.627-635","volume":"11","author":"LA Abdulkhaleq","year":"2018","unstructured":"Abdulkhaleq LA, Assi MA, Abdullah R, Zamri-Saad M, Taufiq-Yap YH, Hezmee MNM (2018) The crucial roles of inflammatory mediators in inflammation: a review. Vet World 11(5):627\u2013635. https:\/\/doi.org\/10.14202\/vetworld.2018.627-635","journal-title":"Vet World"},{"issue":"3","key":"1936_CR3","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/j.1365-2710.2009.01077.x","volume":"35","author":"M Adel","year":"2010","unstructured":"Adel M, Awad HAS, Abdel-Naim AB, Al-Azizi MMM (2010) Effects of pentoxifylline on coagulation profile and disseminated intravascular coagulation incidence in Egyptian septic neonates (Article). J Clin Pharm Ther 35(3):257\u2013265. https:\/\/doi.org\/10.1111\/j.1365-2710.2009.01077.x","journal-title":"J Clin Pharm Ther"},{"issue":"10","key":"1936_CR4","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1055\/s-0033-1363771","volume":"31","author":"A Akdag","year":"2014","unstructured":"Akdag A, Dilmen U, Haque K, Dilli D, Erdeve O, Goekmen T (2014) Role of pentoxifylline and\/or IgM-enriched intravenous immunoglobulin in the management of neonatal sepsis (article). Am J Perinatol 31(10):905\u2013912. https:\/\/doi.org\/10.1055\/s-0033-1363771","journal-title":"Am J Perinatol"},{"issue":"6","key":"1936_CR5","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1053\/gast.2000.20189","volume":"119","author":"E Akriviadis","year":"2000","unstructured":"Akriviadis E, Botla R, Briggs W, Han S, Reynolds T, Shakil O (2000) Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology 119(6):1637\u20131648. https:\/\/doi.org\/10.1053\/gast.2000.20189","journal-title":"Gastroenterology"},{"key":"1936_CR6","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/978-81-322-2680-2_4","volume-title":"Biology of C Reactive Protein in Health and Disease","author":"W Ansar","year":"2016","unstructured":"Ansar W, Ghosh S (2016) Inflammation and Inflammatory Diseases, Markers, and Mediators: Role of CRP in Some Inflammatory Diseases. In: Ansar W, Ghosh S (eds) Biology of C Reactive Protein in Health and Disease. New Delhi, Springer India, pp 67\u2013107"},{"issue":"7","key":"1936_CR7","doi-asserted-by":"publisher","first-page":"521","DOI":"10.5301\/ijao.5000340","volume":"37","author":"SA Antunes","year":"2014","unstructured":"Antunes SA, Vilela RQ, Vaz JD, Canziani MEF (2014) Pentoxifylline does not alter the concentration of hepcidin in chronic kidney disease patients undergoing hemodialysis (article). Int J Artif Organs 37(7):521\u2013528. https:\/\/doi.org\/10.5301\/ijao.5000340","journal-title":"Int J Artif Organs"},{"issue":"6","key":"1936_CR8","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/BF00364972","volume":"1","author":"A Ardizzoia","year":"1993","unstructured":"Ardizzoia A, Lissoni P, Tancini G, Paolorossi F, Crispino S, Villa S et al (1993) Respiratory distress syndrome in patients with advanced cancer treated with pentoxifylline: a randomized study (Article). Support Care Cancer 1(6):331\u2013333. https:\/\/doi.org\/10.1007\/BF00364972","journal-title":"Support Care Cancer"},{"issue":"1","key":"1936_CR9","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/S0022-3476(05)82022-0","volume":"125","author":"SC Aronoff","year":"1994","unstructured":"Aronoff SC, Quinn FJ Jr, Carpenter LS, Novick WJ Jr (1994) Effects of pentoxifylline on sputum neutrophil elastase and pulmonary function in patients with cystic fibrosis: Preliminary observations (Article). J Pediatr 125(1):992\u2013997. https:\/\/doi.org\/10.1016\/S0022-3476(05)82022-0","journal-title":"J Pediatr"},{"issue":"Pt B","key":"1936_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.108227","volume":"101","author":"H Azizi","year":"2021","unstructured":"Azizi H, Rouhani N, Shaki F, Karimpour-Razkenari E, Ghazaeian M, Salehifar E et al (2021) Pentoxifylline effects on hospitalized patients with COVID19: a randomized, double-blind clinical trial. Int Immunopharmacol 101(Pt B):108227. https:\/\/doi.org\/10.1016\/j.intimp.2021.108227","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"1936_CR11","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.1007\/s10787-024-01560-6","volume":"32","author":"MM Bahaa","year":"2024","unstructured":"Bahaa MM, Hegazy SK, Maher MM, Bahgat MM, El-Haggar SM (2024) Pentoxifylline in patients with ulcerative colitis treated with mesalamine by modulation of IL-6\/STAT3, ZO-1, and S1P pathways: a randomized controlled double-blinded study. Inflammopharmacology 32(5):3247\u20133258. https:\/\/doi.org\/10.1007\/s10787-024-01560-6","journal-title":"Inflammopharmacology"},{"issue":"2","key":"1936_CR12","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ejheart.2003.09.005","volume":"6","author":"P Bahrmann","year":"2004","unstructured":"Bahrmann P, Hengst UM, Richartz BM, Figulla HR (2004) Pentoxifylline in ischemic, hypertensive and idiopathic-dilated cardiomyopathy: effects on left-ventricular function, inflammatory cytokines and symptoms (article). Eur J Heart Fail 6(2):195\u2013201. https:\/\/doi.org\/10.1016\/j.ejheart.2003.09.005","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"1936_CR13","doi-asserted-by":"publisher","DOI":"10.5812\/hepatmon.32418","volume":"15","author":"N Baniasadi","year":"2015","unstructured":"Baniasadi N, Salajegheh F, Pardakhty A, Seyedmirzaee SM, Hayatbakhsh MM, Nikpoor AR et al (2015) Effects of pentoxifylline on non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled trial in Iran. Hepat Mon 15(11):e32418. https:\/\/doi.org\/10.5812\/hepatmon.32418","journal-title":"Hepat Mon"},{"key":"1936_CR14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1749-8090-6-8","volume":"6","author":"K Barkhordari","year":"2011","unstructured":"Barkhordari K, Karimi A, Shafiee A, Soltaninia H, Khatami MR, Abbasi K et al (2011) Effect of pentoxifylline on preventing acute kidney injury after cardiac surgery by measuring urinary neutrophil gelatinase - associated lipocalin. J Cardiothorac Surg 6:8. https:\/\/doi.org\/10.1186\/1749-8090-6-8","journal-title":"J Cardiothorac Surg"},{"issue":"5","key":"1936_CR15","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1182\/blood.V78.5.1205.1205","volume":"78","author":"JA Bianco","year":"1991","unstructured":"Bianco JA, Appelbaum FR, Nemunaitis J, Almgren J, Andrews F, Kettner P et al (1991) Phase I-II trial of pentoxifylline for the prevention of transplant-related toxicities following bone marrow transplantation. Blood 78(5):1205\u20131211","journal-title":"Blood"},{"issue":"2","key":"1936_CR16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1042\/cs1030163","volume":"103","author":"W Bilsborough","year":"2002","unstructured":"Bilsborough W, O\u2019Driscoll G, Stanton K, Weerasooriya R, Dembo L, Taylor R et al (2002) Effect of lowering tumour necrosis factor-\u03b1 on vascular endothelial function in type II diabetes (article). Clin Sci 103(2):163\u2013169. https:\/\/doi.org\/10.1042\/cs1030163","journal-title":"Clin Sci"},{"issue":"4","key":"1936_CR17","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3109\/tcic.6.4.153.158","volume":"6","author":"J Boldt","year":"1995","unstructured":"Boldt J, Heesen M, M\u00fcller M, Linke LC, Hempelmann G (1995) Interleukin-10 plasma levels in the critically ill (Article). Clin Intensive Care 6(4):153\u2013158","journal-title":"Clin Intensive Care"},{"issue":"12","key":"1936_CR18","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1097\/hjh.0000000000001086","volume":"34","author":"D Brie","year":"2016","unstructured":"Brie D, Sahebkar A, Penson PE, Dinca M, Ursoniu S, Serban M-C et al (2016) Effects of pentoxifylline on inflammatory markers and blood pressure: a systematic review and meta-analysis of randomized controlled trials. J Hypertens 34(12):2318\u20132329. https:\/\/doi.org\/10.1097\/hjh.0000000000001086","journal-title":"J Hypertens"},{"issue":"6","key":"1936_CR19","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2022.11305","volume":"23","author":"DM Brie","year":"2022","unstructured":"Brie DM, Mornos C, Brie DA, Luca CT, Petrescu L, Boruga M (2022) Potential role for pentoxifylline as an anti-inflammatory drug for patients with acute coronary syndrome. Exp Ther Med 23(6):378","journal-title":"Exp Ther Med"},{"issue":"4","key":"1936_CR20","doi-asserted-by":"publisher","first-page":"617","DOI":"10.4269\/ajtmh.12-0729","volume":"90","author":"G Brito","year":"2014","unstructured":"Brito G, Dourado M, Polari L, Celestino D, Carvalho LP, Queiroz A et al (2014) Clinical and immunological outcome in cutaneous leishmaniasis patients treated with pentoxifylline. Am J Trop Med Hyg 90(4):617\u2013620. https:\/\/doi.org\/10.4269\/ajtmh.12-0729","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"1936_CR21","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1046\/j.1365-2249.2000.01281.x","volume":"121","author":"H Bruunsgaard","year":"2000","unstructured":"Bruunsgaard H, Skinh\u00f8j P, Pedersen AN, Schroll M, Pedersen B (2000) Ageing, tumour necrosis factor-alpha (TNF-\u03b1) and atherosclerosis. Clin Exp Immunol 121(2):255\u2013260","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"1936_CR22","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1191\/0267659105pf779oa","volume":"20","author":"K \u00c7a\u01e7li","year":"2005","unstructured":"\u00c7a\u01e7li K, Ula\u015f MM, \u00d6zi\u015fik K, Kale A, Bakuy V, Emir M et al (2005) The intraoperative effect of pentoxifylline on the inflammatory process and leukocytes in cardiac surgery patients undergoing cardiopulmonary bypass (Article). Perfusion 20(1):45\u201351. https:\/\/doi.org\/10.1191\/0267659105pf779oa","journal-title":"Perfusion"},{"issue":"4","key":"1936_CR23","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3390\/antibiotics12040639","volume":"12","author":"V Cazanga","year":"2023","unstructured":"Cazanga V, Palma C, Casanova T, Rojas D, Barrera K, Valenzuela C et al (2023) Modulation of the acute inflammatory response induced by the Escherichia coli lipopolysaccharide through the interaction of pentoxifylline and florfenicol in a rabbit model. Antibiotics 12(4):639","journal-title":"Antibiotics"},{"key":"1936_CR24","doi-asserted-by":"publisher","DOI":"10.1097\/MS9.0000000000003043","author":"CR Cerda-Cruz","year":"2025","unstructured":"Cerda-Cruz CR, Vazquez-Urrutia JR, Ortiz-Lazareno PC, Villase\u00f1or-Garc\u00eda MM, Cruz-Lozano JR, Hern\u00e1ndez-Flores G et al (2025) Chemotherapy with a molecular rational basis, pentoxifylline as a promising antitumor drug. Ann Med Surg. https:\/\/doi.org\/10.1097\/MS9.0000000000003043","journal-title":"Ann Med Surg"},{"issue":"1","key":"1936_CR25","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1089\/sur.2005.6.73","volume":"6","author":"R Coimbra","year":"2005","unstructured":"Coimbra R, Porcides RD, Melbostad H, Loomis W, Tobar M, Hoyt DB et al (2005) Nonspecific phosphodiesterase inhibition attenuates liver injury in acute endotoxemia. Surg Infect 6(1):73\u201385","journal-title":"Surg Infect"},{"key":"1936_CR26","doi-asserted-by":"crossref","unstructured":"Da Costa, B. R., Pereira, T. V., Saadat, P., Rudnicki, M., Iskander, S. M., Bodmer, N. S., et al. (2021). Effectiveness and safety of non-steroidal anti-inflammatory drugs and opioid treatment for knee and hip osteoarthritis: network meta-analysis. bmj, 375.","DOI":"10.1136\/bmj.n2321"},{"issue":"5","key":"1936_CR27","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1177\/0003319707309656","volume":"59","author":"RM de Albuquerque","year":"2008","unstructured":"de Albuquerque RM, Virgini-Magalh\u00e3es CE, Lencastre Sicuro F, Bottino DA, Bouskela E (2008) Effects of cilostazol and pentoxifylline on forearm reactive hyperemia response, lipid profile, oxidative stress, and inflammatory markers in patients with intermittent claudication. Angiology 59(5):549\u2013558. https:\/\/doi.org\/10.1177\/0003319707309656","journal-title":"Angiology"},{"issue":"4","key":"1936_CR28","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1097\/00007890-199402000-00010","volume":"57","author":"GA DeVault Jr","year":"1994","unstructured":"DeVault GA Jr, Kohan DE, Nelson EW, Holman JM Jr (1994) The effects of oral pentoxifylline on the cytokine release syndrome during inductive OKT3. Transplantation 57(4):532\u2013540","journal-title":"Transplantation"},{"issue":"12","key":"1936_CR29","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S0192-0561(97)85556-7","volume":"18","author":"CL d'Hellencourt","year":"1996","unstructured":"d\u2019Hellencourt CL, Diaw L, Cornillet P, Guenounou M (1996) Differential regulation of TNF\u03b1, IL-1\u03b2, IL-6, IL-8, TNF\u03b2, and IL-10 by pentoxifylline. Int J Immunopharmacol 18(12):739\u2013748","journal-title":"Int J Immunopharmacol"},{"issue":"5","key":"1936_CR30","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1093\/infdis\/171.5.1317","volume":"171","author":"G Di Perri","year":"1995","unstructured":"Di Perri G, Di Perri IG, Monteiro GB, Bonora S, Hennig C, Cassatella M et al (1995) Pentoxifylline as a supportive agent in the treatment of cerebral malaria in children. J Infect Dis 171(5):1317\u20131322. https:\/\/doi.org\/10.1093\/infdis\/171.5.1317","journal-title":"J Infect Dis"},{"issue":"1","key":"1936_CR31","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1186\/s12933-024-02393-x","volume":"23","author":"J Donate-Correa","year":"2024","unstructured":"Donate-Correa J, Ferri CM, Mora-Fern\u00e1ndez C, P\u00e9rez-Delgado N, Gonz\u00e1lez-Luis A, Navarro-Gonz\u00e1lez JF (2024) Pentoxifylline ameliorates subclinical atherosclerosis progression in patients with type 2 diabetes and chronic kidney disease: a randomized pilot trial. Cardiovasc Diabetol 23(1):314. https:\/\/doi.org\/10.1186\/s12933-024-02393-x","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"1936_CR32","first-page":"261","volume":"8","author":"RM El Metwally","year":"2024","unstructured":"El Metwally RM, El Wakeel LM, El Sharkawy M, Elborolossy RM (2024) Pentoxifylline reno-protective and anti-inflammatory effects and potential role in anemia of chronic kidney disease. Arch Pharm Sci Ain Shams Univ 8(2):261\u2013274","journal-title":"Arch Pharm Sci Ain Shams Univ"},{"issue":"3","key":"1936_CR33","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s12072-015-9633-1","volume":"9","author":"SM El-Haggar","year":"2015","unstructured":"El-Haggar SM, Mostafa TM (2015) Comparative clinical study between the effect of fenofibrate alone and its combination with pentoxifylline on biochemical parameters and liver stiffness in patients with non-alcoholic fatty liver disease. Hepatol Int 9(3):471\u2013479. https:\/\/doi.org\/10.1007\/s12072-015-9633-1","journal-title":"Hepatol Int"},{"issue":"6","key":"1936_CR34","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1159\/000492619","volume":"87","author":"SM El-Haggar","year":"2018","unstructured":"El-Haggar SM, Eissa MA, Mostafa TM, El-Attar KS, Abdallah MS (2018) The phosphodiesterase inhibitor pentoxifylline as a novel adjunct to antidepressants in major depressive disorder patients: a proof-of-concept, randomized, double-blind, placebo-controlled trial (article). Psychother Psychosom 87(6):331\u2013339. https:\/\/doi.org\/10.1159\/000492619","journal-title":"Psychother Psychosom"},{"issue":"3","key":"1936_CR35","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jphs.2021.03.011","volume":"146","author":"HM El-Sadek","year":"2021","unstructured":"El-Sadek HM, Al-Shorbagy MY, Awny MM, Abdallah DM, El-Abhar HS (2021) Pentoxifylline treatment alleviates kidney ischemia\/reperfusion injury: novel involvement of galectin-3 and ASK-1\/JNK & ERK1\/2\/NF-\u03baB\/HMGB-1 trajectories. J Pharmacol Sci 146(3):136\u2013148","journal-title":"J Pharmacol Sci"},{"key":"1936_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.envpol.2022.120959","volume":"320","author":"S Elumalai","year":"2023","unstructured":"Elumalai S, Karunakaran U, Won KC, Chung SM, Moon JS (2023) Perfluorooctane sulfonate-induced oxidative stress contributes to pancreatic \u03b2-cell apoptosis by inhibiting cyclic adenosine monophosphate pathway: prevention by pentoxifylline. Environ Pollut 320:120959. https:\/\/doi.org\/10.1016\/j.envpol.2022.120959","journal-title":"Environ Pollut"},{"issue":"3","key":"1936_CR37","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s10787-022-00957-5","volume":"30","author":"S Etemadi","year":"2022","unstructured":"Etemadi S, Abtahi Froushani SM, Hashemi Asl SM, Mahmoudian A (2022) Combined atorvastatin and pentoxifylline in ameliorating inflammation induced by complete Freund\u2019s adjuvant. Inflammopharmacology 30(3):935\u2013944. https:\/\/doi.org\/10.1007\/s10787-022-00957-5","journal-title":"Inflammopharmacology"},{"issue":"1","key":"1936_CR38","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.atherosclerosis.2006.11.032","volume":"196","author":"JL Fernandes","year":"2008","unstructured":"Fernandes JL, de Oliveira RTD, Mamoni RL, Coelho OR, Nicolau JC, Blotta M et al (2008a) Pentoxifylline reduces pro-inflammatory and increases anti-inflammatory activity in patients with coronary artery disease\u2013a randomized placebo-controlled study. Atherosclerosis 196(1):434\u2013442. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2006.11.032","journal-title":"Atherosclerosis"},{"issue":"1","key":"1936_CR39","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.atherosclerosis.2006.11.032","volume":"196","author":"JL Fernandes","year":"2008","unstructured":"Fernandes JL, de Oliveira RTD, Mamoni RL, Coelho OR, Nicolau JC, Blotta MHSL et al (2008b) Pentoxifylline reduces pro-inflammatory and increases anti-inflammatory activity in patients with coronary artery disease\u2014a randomized placebo-controlled study. Atherosclerosis 196(1):434\u2013442. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2006.11.032","journal-title":"Atherosclerosis"},{"issue":"1","key":"1936_CR40","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.atherosclerosis.2006.11.032","volume":"196","author":"JL Fernandes","year":"2008","unstructured":"Fernandes JL, de Oliveira RTD, Mamoni RL, Coelho OR, Nicolau JC, Blotta MHSL et al (2008c) Pentoxifylline reduces pro-inflammatory and increases anti-inflammatory activity in patients with coronary artery disease-a randomized placebo-controlled study (article). Atherosclerosis 196(1):434\u2013442. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2006.11.032","journal-title":"Atherosclerosis"},{"issue":"6","key":"1936_CR41","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/j.1532-5415.1999.tb01583.x","volume":"47","author":"L Ferrucci","year":"1999","unstructured":"Ferrucci L, Harris TB, Guralnik JM, Tracy RP, Corti MC, Cohen HJ et al (1999) Serum IL-6 level and the development of disability in older persons. J Am Geriatr Soc 47(6):639\u2013646","journal-title":"J Am Geriatr Soc"},{"issue":"Suppl 2","key":"1936_CR42","doi-asserted-by":"publisher","first-page":"S96","DOI":"10.1097\/00005344-199500252-00021","volume":"25","author":"C Fossat","year":"1995","unstructured":"Fossat C, Fabre D, Alimi Y, Bienvenu J, Aillaud MF, Lenoble M et al (1995) Leukocyte activation study during occlusive arterial disease of the lower limb: effect of pentoxifylline infusion. J Cardiovasc Pharmacol 25(Suppl 2):S96-100. https:\/\/doi.org\/10.1097\/00005344-199500252-00021","journal-title":"J Cardiovasc Pharmacol"},{"issue":"9","key":"1936_CR43","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/BF02190688","volume":"153","author":"S Furukawa","year":"1994","unstructured":"Furukawa S, Matsubara T, Ino T, Yabuta K, Umezawa Y, Motohashi T (1994) Pentoxifylline and intravenous gamma globulin combination therapy for acute Kawasaki disease (article). Eur J Pediatr 153(9):663\u2013667. https:\/\/doi.org\/10.1007\/BF02190688","journal-title":"Eur J Pediatr"},{"issue":"5","key":"1936_CR44","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1093\/ndt\/gfr579","volume":"27","author":"L Gonz\u00e1lez-Espinoza","year":"2012","unstructured":"Gonz\u00e1lez-Espinoza L, Rojas-Campos E, Medina-P\u00e9rez M, Pe\u00f1a-Quintero P, G\u00f3mez-Navarro B, Cueto-Manzano AM (2012) Pentoxifylline decreases serum levels of tumor necrosis factor alpha, interleukin 6 and C-reactive protein in hemodialysis patients: results of a randomized double-blind, controlled clinical trial. Nephrol Dial Transplant 27(5):2023\u20132028. https:\/\/doi.org\/10.1093\/ndt\/gfr579","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"1936_CR45","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1089\/aid.2011.0385","volume":"28","author":"LA Green","year":"2012","unstructured":"Green LA, Kim C, Gupta SK, Rajashekhar G, Rehman J, Clauss M (2012) Pentoxifylline reduces tumor necrosis factor-\u03b1 and HIV-induced vascular endothelial activation. AIDS Res Hum Retroviruses 28(10):1207\u20131215","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"4","key":"1936_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060852","volume":"8","author":"SK Gupta","year":"2013","unstructured":"Gupta SK, Mi D, Dub\u00e9 MP, Saha CK, Johnson RM, Stein JH et al (2013) Pentoxifylline, inflammation, and endothelial function in HIV-infected persons: a randomized, placebo-controlled trial. PLoS ONE 8(4):e60852. https:\/\/doi.org\/10.1371\/journal.pone.0060852","journal-title":"PLoS ONE"},{"issue":"13","key":"1936_CR47","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1097\/qad.0000000000001172","volume":"30","author":"SK Gupta","year":"2016","unstructured":"Gupta SK, Dub\u00e9 MP, Stein JH, Clauss MA, Liu Z (2016) A pilot trial of pentoxifylline on endothelial function and inflammation in HIV-infected patients initiating antiretroviral therapy. AIDS 30(13):2139\u20132142. https:\/\/doi.org\/10.1097\/qad.0000000000001172","journal-title":"AIDS"},{"key":"1936_CR48","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13098-015-0060-1","volume":"7","author":"SJ Han","year":"2015","unstructured":"Han SJ, Kim HJ, Kim DJ, Sheen SS, Chung CH, Ahn CW et al (2015) Effects of pentoxifylline on proteinuria and glucose control in patients with type 2 diabetes: a prospective randomized double-blind multicenter study. Diabetol Metab Syndr 7:64. https:\/\/doi.org\/10.1186\/s13098-015-0060-1","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"1936_CR49","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s13098-024-01363-3","volume":"16","author":"SK Hegazy","year":"2024","unstructured":"Hegazy SK, Amaar WA, Hegab WSM (2024) Tadalafil versus pentoxifylline in the management of diabetic kidney disease: a randomized clinical trial. Diabetol Metab Syndr 16(1):138. https:\/\/doi.org\/10.1186\/s13098-024-01363-3","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"1936_CR50","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ejcts.2007.04.011","volume":"32","author":"H Heinze","year":"2007","unstructured":"Heinze H, Rosemann C, Weber C, Heinrichs G, Bahlmann L, Misfeld M et al (2007) A single prophylactic dose of pentoxifylline reduces high dependency unit time in cardiac surgery - a prospective randomized and controlled study (Article). Eur J Cardiothorac Surg 32(1):83\u201389. https:\/\/doi.org\/10.1016\/j.ejcts.2007.04.011","journal-title":"Eur J Cardiothorac Surg"},{"issue":"4","key":"1936_CR51","doi-asserted-by":"publisher","first-page":"397","DOI":"10.4269\/ajtmh.1997.56.397","volume":"56","author":"CJ Hemmer","year":"1997","unstructured":"Hemmer CJ, Hort G, Chiwakata CB, Seitz R, Egbring R, Gaus W et al (1997) Supportive pentoxifylline in falciparum malaria: no effect on tumor necrosis factor alpha levels or clinical outcome: a prospective, randomized, placebo-controlled study (article). Am J Trop Med Hyg 56(4):397\u2013403. https:\/\/doi.org\/10.4269\/ajtmh.1997.56.397","journal-title":"Am J Trop Med Hyg"},{"issue":"7414","key":"1936_CR52","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring Inconsistency in Meta-Analyses Bmj 327(7414):557\u2013560. https:\/\/doi.org\/10.1136\/bmj.327.7414.557","journal-title":"Measuring Inconsistency in Meta-Analyses Bmj"},{"key":"1936_CR53","doi-asserted-by":"publisher","unstructured":"Higgins, J. P. T., & Altman, D. G. (2008). Assessing Risk of Bias in Included Studies. Cochrane Handbook for Systematic Reviews of Interventions (pp. 187\u2013241). https:\/\/doi.org\/10.1002\/9780470712184.ch8.","DOI":"10.1002\/9780470712184.ch8"},{"issue":"6","key":"1936_CR54","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1034\/j.1600-6143.2002.20611.x","volume":"2","author":"SC Hoffmann","year":"2002","unstructured":"Hoffmann SC, Stanley EM, Cox ED, DiMercurio BS, Koziol DE, Harlan DM et al (2002) Ethnicity greatly influences cytokine gene polymorphism distribution. Am J Transplant 2(6):560\u2013567","journal-title":"Am J Transplant"},{"issue":"5","key":"1936_CR55","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1245\/ASO.2003.10.005","volume":"10","author":"P Hohenberger","year":"2003","unstructured":"Hohenberger P, Latz E, Kettelhack C, Rezaei AH, Schumann R, Schlag PM (2003) Pentoxifyllin attenuates the systemic inflammatory response induced during isolated limb perfusion with recombinant human tumor necrosis factor-\u03b1 and melphalan (article). Ann Surg Oncol 10(5):562\u2013568. https:\/\/doi.org\/10.1245\/ASO.2003.10.005","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"1936_CR56","doi-asserted-by":"publisher","first-page":"3856","DOI":"10.1093\/jn\/nxab313","volume":"151","author":"E Hulander","year":"2021","unstructured":"Hulander E, B\u00e4rebring L, Wadell AT, Gjertsson I, Calder PC, Winkvist A et al (2021) Proposed anti-inflammatory diet reduces inflammation in compliant, weight-stable patients with rheumatoid arthritis in a randomized controlled crossover trial. J Nutr 151(12):3856\u20133864","journal-title":"J Nutr"},{"issue":"6","key":"1936_CR57","doi-asserted-by":"publisher","first-page":"E883","DOI":"10.1532\/hsf98.20061090","volume":"9","author":"I Iskesen","year":"2006","unstructured":"Iskesen I, Saribulbul O, Cerrahoglu M, Onur E, Destan B, Sirin BH (2006) Pentoxifylline affects cytokine reaction in cardiopulmonary bypass (Article). Heart Surg Forum 9(6):E883-887. https:\/\/doi.org\/10.1532\/hsf98.20061090","journal-title":"Heart Surg Forum"},{"issue":"2","key":"1936_CR58","doi-asserted-by":"publisher","first-page":"E100","DOI":"10.1532\/HSF98.20081153","volume":"12","author":"I Iskesen","year":"2009","unstructured":"Iskesen I, Kurdal AT, Kahraman N, Cerrahoglu M, Sirin BH (2009) Preoperative oral pentoxifylline for management of cytokine reactions in cardiac surgery (Article). Heart Surg Forum 12(2):E100\u2013E104. https:\/\/doi.org\/10.1532\/HSF98.20081153","journal-title":"Heart Surg Forum"},{"issue":"2","key":"1936_CR59","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1089\/end.2008.0474","volume":"23","author":"F Izadpanah","year":"2009","unstructured":"Izadpanah F, Mojtahedzadeh M, Aghamir SMK, Atharikia D, Dashti S, Abbasi A (2009) Effect of intravenous pentoxifylline in inflammatory response in patients undergoing nephrolithotomy (article). J Endourol 23(2):323\u2013328. https:\/\/doi.org\/10.1089\/end.2008.0474","journal-title":"J Endourol"},{"issue":"1","key":"1936_CR60","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1053\/j.ajkd.2014.06.020","volume":"65","author":"DW Johnson","year":"2015","unstructured":"Johnson DW, Pascoe EM, Badve SV, Dalziel K, Cass A, Clarke P et al (2015) A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: the handling erythropoietin resistance with oxpentifylline (HERO) trial. Am J Kidney Dis 65(1):49\u201357. https:\/\/doi.org\/10.1053\/j.ajkd.2014.06.020","journal-title":"Am J Kidney Dis"},{"key":"1936_CR61","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-025-03845-1","author":"O Kassar","year":"2025","unstructured":"Kassar O, Farag N, Selim A, Taman L, Alaa M, Elshahat A et al (2025) Efficacy, safety and mechanistic insights of pentoxifylline in major depressive disorder: a systematic review and meta-analysis of randomized controlled trials. Naunyn Schmiedebergs Arch Pharmacol. https:\/\/doi.org\/10.1007\/s00210-025-03845-1","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"1936_CR62","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/00024382-199801000-00002","volume":"9","author":"S Kleinschmidt","year":"1998","unstructured":"Kleinschmidt S, Wanner GA, Bu\u00dfmann D, Kremer JP, Ziegenfu\u00df T, Menger MD et al (1998) Proinflammatory cytokine gene expression in whole blood from patients undergoing coronary artery bypass surgery and its modulation by pentoxifylline (article). Shock 9(1):12\u201320. https:\/\/doi.org\/10.1097\/00024382-199801000-00002","journal-title":"Shock"},{"issue":"1","key":"1936_CR63","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/SHK.0b013e3181cdc3e2","volume":"34","author":"S Kreth","year":"2010","unstructured":"Kreth S, Ledderose C, Luchting B, Weis F, Thiel M (2010) Immunomodulatory properties of pentoxifylline are mediated via adenosine-dependent pathways. Shock 34(1):10\u201316","journal-title":"Shock"},{"issue":"1","key":"1936_CR64","doi-asserted-by":"publisher","first-page":"17150","DOI":"10.1038\/srep17150","volume":"5","author":"K-L Kuo","year":"2015","unstructured":"Kuo K-L, Hung S-C, Liu J-S, Chang Y-K, Hsu C-C, Tarng D-C (2015) Add-on protective effect of pentoxifylline in advanced chronic kidney disease treated with renin-angiotensin-aldosterone system blockade - a nationwide database analysis. Sci Rep 5(1):17150. https:\/\/doi.org\/10.1038\/srep17150","journal-title":"Sci Rep"},{"issue":"5","key":"1936_CR65","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1007\/BF01955273","volume":"155","author":"R Lauterbach","year":"1996","unstructured":"Lauterbach R, Zembala M (1996) Pentoxifylline reduces plasma tumour necrosis factor-alpha concentration in premature infants with sepsis (article). Eur J Pediatr 155(5):404\u2013409. https:\/\/doi.org\/10.1007\/BF01955273","journal-title":"Eur J Pediatr"},{"issue":"5","key":"1936_CR66","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1053\/j.gastro.2010.01.040","volume":"138","author":"D Lebrec","year":"2010","unstructured":"Lebrec D, Thabut D, Oberti F, Perarnau JM, Condat B, Barraud H et al (2010) Pentoxifylline does not decrease short-term mortality but does reduce complications in patients with advanced cirrhosis. Gastroenterology 138(5):1755\u20131762. https:\/\/doi.org\/10.1053\/j.gastro.2010.01.040","journal-title":"Gastroenterology"},{"issue":"2","key":"1936_CR67","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/S0021-9150(01)00457-9","volume":"158","author":"TM Lee","year":"2001","unstructured":"Lee TM, Su SF, Hwang JJ, Tseng CD, Chen MF, Lee YT et al (2001) Differential lipogenic effects of cilostazol and pentoxifylline in patients with intermittent claudication: potential role for interleukin-6 (article). Atherosclerosis 158(2):471\u2013476. https:\/\/doi.org\/10.1016\/S0021-9150(01)00457-9","journal-title":"Atherosclerosis"},{"issue":"2","key":"1936_CR68","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s12072-008-9058-1","volume":"2","author":"YM Lee","year":"2008","unstructured":"Lee YM, Sutedja DS, Wai CT, Dan YY, Aung MO, Zhou L et al (2008) A randomized controlled pilot study of Pentoxifylline in patients with non-alcoholic steatohepatitis (NASH) (article). Hepatol Int 2(2):196\u2013201. https:\/\/doi.org\/10.1007\/s12072-008-9058-1","journal-title":"Hepatol Int"},{"issue":"20","key":"1936_CR69","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.medcli.2008.05.024","volume":"132","author":"R Leyva-Jim\u00e9nez","year":"2009","unstructured":"Leyva-Jim\u00e9nez R, Rodr\u00edguez-Orozco AR, Ortega-Pierres LE, Ram\u00edrez-Enr\u00edquez J, G\u00f3mez-Garc\u00eda A, Alvarez-Aguilar C (2009) Effect of pentoxifylline on the evolution of diabetic nephropathy (Article). Med Clin 132(20):772\u2013778. https:\/\/doi.org\/10.1016\/j.medcli.2008.05.024","journal-title":"Med Clin"},{"issue":"5","key":"1936_CR70","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1213\/01.ANE.0000132974.32249.C8","volume":"99","author":"CH Lu","year":"2004","unstructured":"Lu CH, Chao PC, Borel CO, Yang CP, Yeh CC, Wong CS et al (2004) Preincisional intravenous pentoxifylline attenuating perioperative cytokine response, reducing morphine consumption, and improving recovery of bowel function in patients undergoing colorectal cancer surgery (Article). Anesth Analg 99(5):1465\u20131471. https:\/\/doi.org\/10.1213\/01.ANE.0000132974.32249.C8","journal-title":"Anesth Analg"},{"issue":"2\u20133","key":"1936_CR71","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.vph.2007.05.004","volume":"47","author":"R Maiti","year":"2007","unstructured":"Maiti R, Agrawal NK, Dash D, Pandey BL (2007) Effect of pentoxifylline on inflammatory burden, oxidative stress and platelet aggregability in hypertensive type 2 diabetes mellitus patients. Vascul Pharmacol 47(2\u20133):118\u2013124. https:\/\/doi.org\/10.1016\/j.vph.2007.05.004","journal-title":"Vascul Pharmacol"},{"issue":"3","key":"1936_CR72","first-page":"247","volume":"18","author":"F Malekifard","year":"2015","unstructured":"Malekifard F, Delirezh N, Hobbenaghi R, Malekinejad H (2015) Immunotherapeutic effects of pentoxifylline in type 1 diabetic mice and its role in the response of T-helper lymphocytes. Iran J Basic Med Sci 18(3):247\u2013252","journal-title":"Iran J Basic Med Sci"},{"issue":"12","key":"1936_CR73","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.5152\/akd.2014.5883","volume":"15","author":"S Mansourian","year":"2015","unstructured":"Mansourian S, Bina P, Fehri A, Karimi AA, Boroumand MA, Abbasi K (2015) Preoperative oral pentoxifylline in case of coronary artery bypass grafting with left ventricular dysfunction (ejection fraction equal to\/less than 30%). Anatol J Cardiol 15(12):1014\u20131019. https:\/\/doi.org\/10.5152\/akd.2014.5883","journal-title":"Anatol J Cardiol"},{"issue":"4","key":"1936_CR74","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1055\/a-2291-7204","volume":"57","author":"TA Merza Mohammad","year":"2024","unstructured":"Merza Mohammad TA, Merza Mohammad TA, Salman DM, Jaafar HM (2024) Pentoxifylline as a novel add-on therapy for major depressive disorder in adult patients: a randomized, double-blind, placebo-controlled trial. Pharmacopsychiatry 57(4):205\u2013214. https:\/\/doi.org\/10.1055\/a-2291-7204","journal-title":"Pharmacopsychiatry"},{"key":"1936_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2024.111047","volume":"216","author":"TAM Mohammad","year":"2024","unstructured":"Mohammad TAM, Mohammad TAM, Shawis TN (2024) Efficacy of pentoxifylline for the treatment of bipolar I\/II patients with treatment-resistant depression: a proof-of-concept, randomized, double-blind, placebo-controlled trial. Brain Res Bull 216:111047. https:\/\/doi.org\/10.1016\/j.brainresbull.2024.111047","journal-title":"Brain Res Bull"},{"issue":"1","key":"1936_CR76","doi-asserted-by":"publisher","first-page":"73","DOI":"10.4103\/1319-2442.124492","volume":"25","author":"AH Mohammadpour","year":"2014","unstructured":"Mohammadpour AH, Nazemian F, Khaiat MH, Tafaghodi M, Salari P, Charkazi S et al (2014) Evaluation of the effect of pentoxifylline on erythropoietin-resistant anemia in hemodialysis patients (Article). Saudi Journal of Kidney Diseases and Transplantation\u202f: an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia 25(1):73\u201378. https:\/\/doi.org\/10.4103\/1319-2442.124492","journal-title":"Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia"},{"issue":"7","key":"1936_CR77","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097. https:\/\/doi.org\/10.1371\/journal.pmed.1000097","journal-title":"PLoS Med"},{"issue":"5","key":"1936_CR78","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1007\/s13300-022-01250-y","volume":"13","author":"F Moosaie","year":"2022","unstructured":"Moosaie F, Rabizadeh S, Fallahzadeh A, Sheikhy A, Meysamie A, Dehghani Firouzabadi F et al (2022) Effects of pentoxifylline on serum markers of diabetic nephropathy in type 2 diabetes (article). Diabetes Ther 13(5):1023\u20131036. https:\/\/doi.org\/10.1007\/s13300-022-01250-y","journal-title":"Diabetes Ther"},{"issue":"3","key":"1936_CR79","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1046\/j.1440-1754.2003.00129.x","volume":"39","author":"N Narin","year":"2003","unstructured":"Narin N, Karakukcu M, Narin F, Akcakus M, Erez R, Halici C (2003) Is pentoxifylline therapy effective for the treatment of acute rheumatic carditis? A pilot study (article). J Paediatr Child Health 39(3):214\u2013218. https:\/\/doi.org\/10.1046\/j.1440-1754.2003.00129.x","journal-title":"J Paediatr Child Health"},{"issue":"5","key":"1936_CR80","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.jdiacomp.2010.09.003","volume":"25","author":"JF Navarro-Gonz\u00e1lez","year":"2011","unstructured":"Navarro-Gonz\u00e1lez JF, Muros M, Mora-Fern\u00e1ndez C, Herrera H, Meneses B, Garc\u00eda J (2011) Pentoxifylline for renoprotection in diabetic nephropathy: the PREDIAN study. Rationale and basal results. J Diabetes Complications 25(5):314\u2013319. https:\/\/doi.org\/10.1016\/j.jdiacomp.2010.09.003","journal-title":"J Diabetes Complications"},{"issue":"8","key":"1936_CR81","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.2337\/dc18-0078","volume":"41","author":"JF Navarro-Gonz\u00e1lez","year":"2018","unstructured":"Navarro-Gonz\u00e1lez JF, S\u00e1nchez-Ni\u00f1o MD, Donate-Correa J, Mart\u00edn-N\u00fa\u00f1ez E, Ferri C, P\u00e9rez-Delgado N et al (2018) Effects of pentoxifylline on soluble Klotho concentrations and renal tubular cell expression in diabetic kidney disease. Diabetes Care 41(8):1817\u20131820. https:\/\/doi.org\/10.2337\/dc18-0078","journal-title":"Diabetes Care"},{"issue":"3","key":"1936_CR82","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/00000421-199506000-00002","volume":"18","author":"J Nemunaitis","year":"1995","unstructured":"Nemunaitis J, Rosenfeld C, Getty L, Boegel F, Meyer W, Jennings LW et al (1995) Pentoxifylline and ciprofloxacin in patients with myelodysplastic syndrome. A phase II trial. Am J Clin Oncol 18(3):189\u2013193. https:\/\/doi.org\/10.1097\/00000421-199506000-00002","journal-title":"Am J Clin Oncol"},{"key":"1936_CR83","doi-asserted-by":"publisher","DOI":"10.21037\/aoj-23-55","volume":"9","author":"CP Olson","year":"2024","unstructured":"Olson CP, Kennedy MI, DePhillipo NN, Tagliero AJ, LaPrade RF, Kennedy NI (2024) Effect of anti-inflammatory treatments on patient outcomes and concentrations of inflammatory modulators in the post-surgical and post-traumatic tibiofemoral joint setting: a narrative review. Annals of Joint 9:9. https:\/\/doi.org\/10.21037\/aoj-23-55","journal-title":"Annals of Joint"},{"issue":"2","key":"1936_CR84","first-page":"69","volume":"62","author":"S Otani","year":"2008","unstructured":"Otani S, Kuinose M, Murakami T, Saito S, Iwagaki H, Tanaka N et al (2008) Preoperative oral administration of pentoxifylline ameliorates respiratory index after cardiopulmonary bypass through decreased production of IL-6 (Article). Acta Med Okayama 62(2):69\u201374","journal-title":"Acta Med Okayama"},{"issue":"1","key":"1936_CR85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.46439\/nephrology.4.013","volume":"4","author":"M Pakfetrat","year":"2023","unstructured":"Pakfetrat M, Malekmakan L, Rezazadeh MH, Aghajanzade P (2023) Effect of pentoxifylline on the dose of erythropoietin among hemodialysis patients: a double-blind randomized clinical trial. J Exp Nephrol 4(1):1\u20135","journal-title":"J Exp Nephrol"},{"issue":"13","key":"1936_CR86","doi-asserted-by":"publisher","first-page":"10592","DOI":"10.3390\/ijms241310592","volume":"24","author":"LA Palafox-Mariscal","year":"2023","unstructured":"Palafox-Mariscal LA, Ortiz-Lazareno PC, Jave-Su\u00e1rez LF, Aguilar-Lemarroy A, Villase\u00f1or-Garc\u00eda MM, Cruz-Lozano JR et al (2023) Pentoxifylline inhibits TNF-\u03b1\/TGF-\u03b21-induced epithelial-mesenchymal transition via suppressing the NF-\u03baB pathway and SERPINE1 expression in CaSki cells. Int J Mol Sci 24(13):10592","journal-title":"Int J Mol Sci"},{"issue":"5","key":"1936_CR87","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.amjms.2017.12.015","volume":"355","author":"S Rabizadeh","year":"2018","unstructured":"Rabizadeh S, Dehghani Firouzabadi F, Noshad S, Esteghamati S, Afarideh M, Ghajar A et al (2018) Beneficial effects of pentoxifylline plus Losartan dual therapy in type 2 diabetes with nephropathy. Am J Med Sci 355(5):442\u2013448. https:\/\/doi.org\/10.1016\/j.amjms.2017.12.015","journal-title":"Am J Med Sci"},{"issue":"4","key":"1936_CR88","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s13539-013-0115-9","volume":"4","author":"M Rattanasompattikul","year":"2013","unstructured":"Rattanasompattikul M, Molnar MZ, Lee ML, Dukkipati R, Bross R, Jing J et al (2013) Anti-inflammatory and anti-oxidative nutrition in hypoalbuminemic dialysis patients (AIONID) study: results of the pilot-feasibility, double-blind, randomized, placebo-controlled trial. J Cachexia Sarcopenia Muscle 4(4):247\u2013257. https:\/\/doi.org\/10.1007\/s13539-013-0115-9","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"3","key":"1936_CR89","doi-asserted-by":"publisher","first-page":"304","DOI":"10.34172\/PS.2024.3","volume":"30","author":"L Rezadoost","year":"2024","unstructured":"Rezadoost L, Tayebi-Khosroshahi H, Farnood F, Sarbakhsh P, Behzad H, Noshad H et al (2024) Effects of Pentoxifylline on Inflammatory Factors and Quality of Life in Maintenance Hemodialysis Patients (Article). Pharmaceut Sci 30(3):304\u2013311. https:\/\/doi.org\/10.34172\/PS.2024.3","journal-title":"Pharmaceut Sci"},{"issue":"1","key":"1936_CR90","doi-asserted-by":"publisher","DOI":"10.2144\/fsoa-2023-0266","volume":"10","author":"A Saeed","year":"2024","unstructured":"Saeed A, Farouk MM, Sabri NA, Saleh MA, Ahmed MA (2024) Effect of pentoxifylline on endothelial dysfunction, oxidative stress and inflammatory markers in STEMI patients. Future Sci OA 10(1):Fso967. https:\/\/doi.org\/10.2144\/fsoa-2023-0266","journal-title":"Future Sci OA"},{"issue":"1","key":"1936_CR91","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s43094-024-00691-5","volume":"10","author":"SS Saleh","year":"2024","unstructured":"Saleh SS, Sherif DEM, Sabri NA, Shawki MA (2024) Evaluation of the effect of pentoxifylline on the prevention of paclitaxel-induced peripheral neuropathy in breast cancer patients: a randomized controlled study. Future J Pharm Sci 10(1):140. https:\/\/doi.org\/10.1186\/s43094-024-00691-5","journal-title":"Future J Pharm Sci"},{"issue":"7","key":"1936_CR92","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1097\/INF.0b013e3182575e6a","volume":"31","author":"D Salgado","year":"2012","unstructured":"Salgado D, Zabaleta TE, Hatch S, Vega MR, Rodriguez J (2012) Use of pentoxifylline in treatment of children with dengue hemorrhagic fever (Article). Pediatr Infect Dis J 31(7):771\u2013773. https:\/\/doi.org\/10.1097\/INF.0b013e3182575e6a","journal-title":"Pediatr Infect Dis J"},{"key":"1936_CR93","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199701000-00009","author":"S S\u00e1nchez","year":"1997","unstructured":"S\u00e1nchez S, Albornoz L, Bandi JC, Gerona S, Mastai R (1997) Pentoxifylline, a drug with rheological effects, decreases portal pressure in an experimental model of cirrhosis. Eur J Gastroenterol Hepatol. https:\/\/doi.org\/10.1097\/00042737-199701000-00009","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1936_CR94","doi-asserted-by":"publisher","DOI":"10.3390\/ph16040631","author":"RM Sarhan","year":"2023","unstructured":"Sarhan RM, Altyar AE, Essam Abou Warda A, Saied YM, Ibrahim HS, Schaalan MF et al (2023) Pentoxifylline effects on hospitalized COVID-19 patients with Cytokine Storm Syndrome: A Randomized Clinical Trial. Pharmaceuticals (Basel). https:\/\/doi.org\/10.3390\/ph16040631","journal-title":"Pharmaceuticals (Basel)"},{"issue":"3","key":"1936_CR95","first-page":"391","volume":"59","author":"K Selim","year":"2004","unstructured":"Selim K, H\u00fcseyin C, Ibrahim KH, Hasan BU, Kazim U, H\u00fcseyin K (2004) Effect of pentoxifylline on tumor necrosis factor-alpha and interleukin-6 levels in neonatal sepsis (Article). Med J Malaysia 59(3):391\u2013394","journal-title":"Med J Malaysia"},{"issue":"4","key":"1936_CR96","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.jceh.2012.10.010","volume":"2","author":"BC Sharma","year":"2012","unstructured":"Sharma BC, Kumar A, Garg V, Reddy RS, Sakhuja P, Sarin SK (2012) A randomized controlled trial comparing efficacy of Pentoxifylline and Pioglitazone on metabolic factors and liver histology in patients with non-alcoholic steatohepatitis. J Clin Exp Hepatol 2(4):333\u2013337. https:\/\/doi.org\/10.1016\/j.jceh.2012.10.010","journal-title":"J Clin Exp Hepatol"},{"key":"1936_CR97","doi-asserted-by":"publisher","first-page":"64","DOI":"10.47176\/mjiri.38.64","volume":"38","author":"S Shirzadeh","year":"2024","unstructured":"Shirzadeh S, Omidkhoda N, Mohammadpour AH, Mannani R, Jomehzadeh V (2024) Evaluation of Preventive Pentoxifylline Effect on Acute Respiratory Distress Syndrome (ARDS) incidence in traumatic patients: a randomized triple-blind placebo-controlled trial. Med J Islam Repub Iran 38:64. https:\/\/doi.org\/10.47176\/mjiri.38.64","journal-title":"Med J Islam Repub Iran"},{"key":"1936_CR98","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23020716","author":"O Sierawska","year":"2022","unstructured":"Sierawska O, Ma\u0142kowska P, Taskin C, Hrynkiewicz R, Mertowska P, Grywalska E et al (2022) Innate immune system response to burn damage\u2014focus on cytokine alteration. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23020716","journal-title":"Int J Mol Sci"},{"issue":"9109","key":"1936_CR99","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S0140-6736(97)09338-0","volume":"351","author":"K Sliwa","year":"1998","unstructured":"Sliwa K, Skudicky D, Candy G, Wisenbaugh T, Sareli P (1998) Randomised investigation of effects of pentoxifylline on left-ventricular performance in idiopathic dilated cardiomyopathy. Lancet 351(9109):1091\u20131093. https:\/\/doi.org\/10.1016\/S0140-6736(97)09338-0","journal-title":"Lancet"},{"issue":"3","key":"1936_CR100","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S1388-9842(02)00008-9","volume":"4","author":"K Sliwa","year":"2002","unstructured":"Sliwa K, Skudicky D, Candy G, Bergemann A, Hopley M, Sareli P (2002a) The addition of pentoxifylline to conventional therapy improves outcome in patients with peripartum cardiomyopathy (article). Eur J Heart Fail 4(3):305\u2013309. https:\/\/doi.org\/10.1016\/S1388-9842(02)00008-9","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"1936_CR101","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/S0002-9149(02)02779-0","volume":"90","author":"K Sliwa","year":"2002","unstructured":"Sliwa K, Woodiwiss A, Candy G, Badenhorst D, Libhaber C, Norton G et al (2002b) Effects of pentoxifylline on cytokine profiles and left ventricular performance in patients with decompensated congestive heart failure secondary to idiopathic dilated cardiomyopathy (article). Am J Cardiol 90(10):1118\u20131122. https:\/\/doi.org\/10.1016\/S0002-9149(02)02779-0","journal-title":"Am J Cardiol"},{"issue":"6","key":"1936_CR102","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1161\/01.CIR.0000112568.48837.60","volume":"109","author":"K Sliwa","year":"2004","unstructured":"Sliwa K, Woodiwiss A, Kone VN, Candy G, Badenhorst D, Norton G et al (2004) Therapy of ischemic cardiomyopathy with the immunomodulating agent pentoxifylline: results of a randomized study (article). Circulation 109(6):750\u2013755. https:\/\/doi.org\/10.1161\/01.CIR.0000112568.48837.60","journal-title":"Circulation"},{"issue":"5","key":"1936_CR103","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/pr.2017.6","volume":"81","author":"EM Speer","year":"2017","unstructured":"Speer EM, Dowling DJ, Ozog LS, Xu J, Yang J, Kennady G et al (2017) Pentoxifylline inhibits TLR- and inflammasome-mediated in vitro inflammatory cytokine production in human blood with greater efficacy and potency in newborns. Pediatr Res 81(5):806\u2013816. https:\/\/doi.org\/10.1038\/pr.2017.6","journal-title":"Pediatr Res"},{"issue":"5","key":"1936_CR104","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0196352","volume":"13","author":"EM Speer","year":"2018","unstructured":"Speer EM, Dowling DJ, Xu J, Ozog LS, Mathew JA, Chander A et al (2018) Pentoxifylline, dexamethasone and azithromycin demonstrate distinct age-dependent and synergistic inhibition of TLR- and inflammasome-mediated cytokine production in human newborn and adult blood in vitro. PLoS ONE 13(5):e0196352. https:\/\/doi.org\/10.1371\/journal.pone.0196352","journal-title":"PLoS ONE"},{"issue":"9","key":"1936_CR105","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1007\/BF02044112","volume":"22","author":"T Staudinger","year":"1996","unstructured":"Staudinger T, Presterl E, Graninger W, Locker GJ, Knapp S, Laczika K et al (1996) Influence of pentoxifylline on cytokine levels and inflammatory parameters in septic shock (article). Intensive Care Med 22(9):888\u2013893. https:\/\/doi.org\/10.1007\/BF02044112","journal-title":"Intensive Care Med"},{"issue":"11","key":"1936_CR106","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1002\/sim.1187","volume":"21","author":"SG Thompson","year":"2002","unstructured":"Thompson SG, Higgins JP (2002) How should meta-regression analyses be undertaken and interpreted? Stat Med 21(11):1559\u20131573. https:\/\/doi.org\/10.1002\/sim.1187","journal-title":"Stat Med"},{"issue":"5","key":"1936_CR107","doi-asserted-by":"publisher","first-page":"M429","DOI":"10.1097\/00002480-199609000-00025","volume":"42","author":"GMK Tsang","year":"1996","unstructured":"Tsang GMK, Allen S, Pagano D, Wong C, Graham TR, Bonser RS (1996) Pentoxifylline preloading reduces endothelial injury and permeability in cardiopulmonary bypass (Review). ASAIO J 42(5):M429\u2013M434. https:\/\/doi.org\/10.1097\/00002480-199609000-00025","journal-title":"ASAIO J"},{"issue":"2","key":"1936_CR108","first-page":"27","volume":"8","author":"I Tuncer","year":"2003","unstructured":"Tuncer I, Uygan I, D\u00fclger H, T\u00fcrkdo\u01e7an K, \u015eekero\u01e7lu R, K\u00f6sem M (2003) The comparative effects of pentoxifylline and ursodeoxycholic acid on IL-1\u03b2, IL-6, IL-8 AND TNF-\u03b1 Levels in Nonalcoholic Fatty Liver. Eastern J Med 8(2):27\u201332","journal-title":"Eastern J Med"},{"issue":"5","key":"1936_CR109","doi-asserted-by":"publisher","first-page":"329","DOI":"10.2165\/00044011-200222050-00007","volume":"22","author":"PR Usha","year":"2002","unstructured":"Usha PR, Naidu MUR, Datla R (2002) Clinical efficacy and tolerability evaluation of pentoxifylline in rheumatoid arthritis: a double-blind, randomised, placebo-controlled study (Article). Clin Drug Investig 22(5):329\u2013339. https:\/\/doi.org\/10.2165\/00044011-200222050-00007","journal-title":"Clin Drug Investig"},{"issue":"4","key":"1936_CR110","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1053\/rmed.2001.1255","volume":"96","author":"H \u00dcst\u00fcnsoy","year":"2002","unstructured":"\u00dcst\u00fcnsoy H, Sivrikoz MC, Bakir K, Enkaya I, Erba \u01e6, B., U\u00e7ak, R., et al (2002) The inhibition of pro-inflammatory cytokines with pentoxifylline in the cardiopulmunary bypass lung (Article). Respirat Med 96(4):275\u2013279. https:\/\/doi.org\/10.1053\/rmed.2001.1255","journal-title":"Respirat Med"},{"issue":"7","key":"1936_CR111","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/sj.bjp.0705999","volume":"143","author":"ML Vale","year":"2004","unstructured":"Vale ML, Benevides VM, Sachs D, Brito GA, da Rocha FA, Poole S et al (2004) Antihyperalgesic effect of pentoxifylline on experimental inflammatory pain. Br J Pharmacol 143(7):833","journal-title":"Br J Pharmacol"},{"issue":"3","key":"1936_CR112","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/s1665-2681(19)31539-x","volume":"10","author":"LB van Wagner","year":"2011","unstructured":"van Wagner LB, Koppe SWP, Brunt EM, Gottstein J, Gardikiotes K, Green RM et al (2011) Pentoxifylline for the treatment of non-alcoholic steatohepatitis: a randomized controlled trial (Article). Ann Hepatol 10(3):277\u2013286. https:\/\/doi.org\/10.1016\/s1665-2681(19)31539-x","journal-title":"Ann Hepatol"},{"issue":"2","key":"1936_CR113","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1053\/j.gastro.2015.04.019","volume":"149","author":"SS Vege","year":"2015","unstructured":"Vege SS, Atwal T, Bi Y, Chari ST, Clemens MA, Enders FT (2015) Pentoxifylline Treatment in Severe Acute Pancreatitis: A Pilot, Double-Blind, Placebo-Controlled. Randomized Trial Gastroenterol 149(2):318\u201320.e3. https:\/\/doi.org\/10.1053\/j.gastro.2015.04.019","journal-title":"Randomized Trial Gastroenterol"},{"issue":"8","key":"1936_CR114","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1016\/j.pan.2020.09.023","volume":"20","author":"SS Vege","year":"2020","unstructured":"Vege SS, Horibe M, Chari ST, Clemens MA, Loftus CG, Enders FT (2020) A single center randomized double blind controlled trial of pentoxifylline in acute pancreatitis: challenges and opportunities (article). Pancreatology 20(8):1592\u20131597. https:\/\/doi.org\/10.1016\/j.pan.2020.09.023","journal-title":"Pancreatology"},{"issue":"3","key":"1936_CR115","doi-asserted-by":"publisher","first-page":"343","DOI":"10.4269\/ajtmh.1998.58.343","volume":"58","author":"C Wenisch","year":"1998","unstructured":"Wenisch C, Looareesuwan S, Wilairatana P, Parschalk B, Vannapann S, Wanaratana V et al (1998) Effect of pentoxifylline on cytokine patterns in the therapy of complicated Plasmodium falciparum malaria (article). Am J Trop Med Hyg 58(3):343\u2013347. https:\/\/doi.org\/10.4269\/ajtmh.1998.58.343","journal-title":"Am J Trop Med Hyg"},{"key":"1936_CR116","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154368","volume":"106","author":"D Xu","year":"2022","unstructured":"Xu D, Zhao W, Feng Y, Wen X, Liu H, Ping J (2022) Pentoxifylline attenuates nonalcoholic fatty liver by inhibiting hepatic macrophage polarization to the M1 phenotype. Phytomedicine 106:154368","journal-title":"Phytomedicine"},{"issue":"8678\u20138679","key":"1936_CR117","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1016\/S0140-6736(89)92929-2","volume":"334","author":"P Zabel","year":"1989","unstructured":"Zabel P, Sch\u00f6nharting MM, Wolter DT, Schade UF (1989) Oxpentifylline in endotoxaemia (Article). The Lancet 334(8678\u20138679):1474\u20131477. https:\/\/doi.org\/10.1016\/S0140-6736(89)92929-2","journal-title":"The Lancet"},{"issue":"8","key":"1936_CR118","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1080\/00325481.2024.2426448","volume":"136","author":"H Zakaria","year":"2024","unstructured":"Zakaria H, Hamdy NA, Sayed-Ahmed NA, El-Mallah A (2024a) Pentoxifylline improves anemia through its novel effect on hypoxia-inducible factor-2 alpha in hemodialysis patients: a randomized, double-blind, placebo-controlled clinical trial. Postgrad Med 136(8):847\u2013854. https:\/\/doi.org\/10.1080\/00325481.2024.2426448","journal-title":"Postgrad Med"},{"key":"1936_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcli.2024.09.032","author":"H Zakaria","year":"2024","unstructured":"Zakaria H, Hamdy NA, Sayed-Ahmed NAH, El-Mallah A (2024b) Effect of pentoxifylline on hepcidin and iron profile in hemodialysis patients: a randomized, double-blind, placebo-controlled clinical trial. Med Clin (Barc). https:\/\/doi.org\/10.1016\/j.medcli.2024.09.032","journal-title":"Med Clin (Barc)"},{"issue":"6","key":"1936_CR120","first-page":"43","volume":"6","author":"Z Zakeri","year":"2014","unstructured":"Zakeri Z, Hashemi SM, Mohammadi M, Yousefi J, Sarani H (2014) Effect of pentoxifylline on correction of anaemia due to chronic diseases in systemic lupus erythematosus (Article). Pharm Lett 6(6):43\u201350","journal-title":"Pharm Lett"},{"issue":"5","key":"1936_CR121","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1002\/hep.24544","volume":"54","author":"CO Zein","year":"2011","unstructured":"Zein CO, Yerian LM, Gogate P, Lopez R, Kirwan JP, Feldstein AE et al (2011) Pentoxifylline improves nonalcoholic steatohepatitis: a randomized placebo-controlled trial. Hepatology 54(5):1610\u20131619. https:\/\/doi.org\/10.1002\/hep.24544","journal-title":"Hepatology"},{"issue":"2","key":"1936_CR122","first-page":"103","volume":"9","author":"M Zhang","year":"2004","unstructured":"Zhang M, Xu YJ, Mengi SA, Arneja AS, Dhalla NS (2004) Therapeutic potentials of pentoxifylline for treatment of cardiovascular diseases. Exp Clin Cardiol 9(2):103\u2013111","journal-title":"Exp Clin Cardiol"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01936-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-025-01936-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01936-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T19:04:57Z","timestamp":1761332697000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-025-01936-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,10]]},"references-count":122,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["1936"],"URL":"https:\/\/doi.org\/10.1007\/s10787-025-01936-2","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,10]]},"assertion":[{"value":"2 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declaration"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}]}}